2012 annual financial data
Sonoma Pharmaceuticals 2012 Operating margin
Direct answer
Operating margin was -50.75%.
Operating income was -6,467,000 USD and net income was -7,329,000 USD.
Operating cash flow was -4,032,000 USD.
Get free Sonoma Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 12,744,000 USD
- Operating income
- -6,467,000 USD
- Net income
- -7,329,000 USD
- Operating cash flow
- -4,032,000 USD